$11 million COVID booster campaign yet to have an impact Halfway through the advertising blitz, Australia’s third dose coverage has increased by just 0.3%. GPs say the money would be better spent supporting providers.
Doctors and pharmacists in united call to continue subsidised COVID tests The COVID-19 Rapid Test Concessional Access Program will not be extended beyond the end of July, despite the ongoing BA.5 wave.
Medication reviews linked to lower death risk in aged care But fewer than one in four residents in aged care facilities are accessing the free service, new research has revealed.
Expanded COVID antivirals access hindered by telehealth restrictions While more people are now eligible to receive treatment through the PBS, GPs warn that vulnerable patients risk being left behind due to a lack of MBS support for extended phone consultations.
Permanent extension of UTI prescribing pilot slammed by doctors Medical groups say the decision sets a terrible precedent for patient safety and is a step backwards for women’s health.
In Practice: Changes to NDIS Act The amendments came into effect on 1 July and are designed to deliver a better experience and outcomes for participants, families and care.
GP22 a chance to start vital paradigm shift The RACGP’s annual conference will this year host three plenary sessions exploring how prevention can become a larger part of the healthcare system.
Extra 7.4 million eligible for fourth COVID shot ATAGI recommends that everyone aged 50–64 should get a second booster, while those between 30–49 may also receive a fourth dose.
AHPRA naming Bill recommended by Senate Committee The proposed legislation will allow information regarding complaints to be made public before investigations are complete.
New diabetes medication shortage will impact patient care The semaglutide shortage is having a flow on effect, with dulaglutide now also in short supply until at least the end of August.